Statistical analysis of illness-death processes and semicompeting risks Data

Biometrics

Volumn 66, Issue 3, 2010, Pages 716-725

  Xu, Jinfeng ^a   Kalbfleisch, John D ^b   Tai, Beechoo ^c  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b UNIVERSITY OF MICHIGAN SCHOOL OF PUBLIC HEALTH   (United States)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Copula; Dependent censoring; Frailty; Illness death model; Proportional hazards; Semicompeting risks data; Terminal event

Indexed keywords

DISEASES; MAXIMUM LIKELIHOOD ESTIMATION;

COPULA; DEATH PROCESS; DEPENDENT CENSORING; FAILURE TIME; FRAILTY; ILLNESS-DEATH MODEL; LATENT FAILURES; PROPORTIONAL HAZARDS; SEMICOMPETING RISK DATA; TERMINAL EVENT;

RISK ASSESSMENT;

ALGORITHM; CANCER; NUMERICAL MODEL; RISK FACTOR; STATISTICAL ANALYSIS; SURVIVAL;

EID: 77956798454     PISSN: 0006341X     EISSN: 15410420     Source Type: Journal    
DOI: 10.1111/j.1541-0420.2009.01340.x     Document Type: Article

References (19)

1. Andersen, P. K., Borgan, O., Gill, R. D., and Keiding, N. (1993). Statistical Models Based on Counting Processes. New York : Springer.
2. Andersen, P. K., Klein, J. P., Knudsen, K. M., and Palacios, R. T. (1997). Estimation of variance in Cox's regression model with shared gamma frailties. Biometrics 53, 1475 1484.
3. Clayton, D. G. (1978). A model for association in bivariate life tables and its application to epidemiological studies of familiar tendency in chronic disease epidemiology. Biometrika 65, 141 151.
4. Day R., Bryant, J., and Lefkopoulou, M. (1997). Adaptation of bivariate frailty models for prediction, with application to biological markers as prognostic factors. Biometrika 84, 45 56.
5. Fine, J. P., Jiang, H., and Chappell, R. (2001). On semi-competing risks data. Biometrika 88, 907 939.
6. Fix, E. and Neyman, J. (1951). A simple stochastic model of recovery, relapse, death and loss of patients. Human Biology 23, 205 241.
7. Glidden, D. V. (1997). Pairwise dependence diagnostics for clustered failure-time data. Biometrika 94, 371 385.
8. Kalbfleisch, J. D. and Prentice, R. L. (2002). The Statistical Analysis of Failure Time Data. Hoboken, New Jersey : Wiley.
9. Liu, L., Wolfe, R. A., and Huang, X. (2004). Shared frailty model for recurrent events and a terminal event. Biometrics 60, 747 756.
10. Murphy, S. A. (1995). Asymptotic theory for the frailty model. Annals of Statistics 23, 182 198.
11. Murphy, S. A. and van der Vaart, A. W. (2000). On profile likelihood. Journal of the American Statistical Association 95, 449 465.
12. Nielsen, G. G., Gill, R. D., Andersen, P. K., and Sørensen, T. I. A. (1992). A counting process approach to maximum likelihood estimation in frailty models. Scandinavian Journal of Statistics 19, 25 43.
13. Oakes, D. (1982). A model for association in bivariate survival data. Journal of the Royal Statistical Society, Series B 44, 414 422.
14. Parner, E. (1998). Asymptotic theory for the correlated gamma-frailty model. Annals of Statistics 26, 183 214.
15. Peng, L. and Fine, J. P. (2007). Regression modeling of semi-competing risks data. Biometrics 63, 96 108.
16. Prentice, R. L., Kalbfleisch, J. D., Peterson, A. V., Flournoy, N., Farewell, V. T., and Breslow, N. E. (1978). The analysis of failure times in the presence of competing risks. Biometrics 34, 541 554.
17. Sverdrup, E. (1965). Estimates and test procedures in connection with stochastic models for deaths, recoveries and transfers between different states of health. Skand. Aktuarietietidskr 48, 184 211.
18. Wang, W. (2003). Estimating the association parameter for copula models under dependent censoring. Journal of the Royal Statistical Society, Series B 65, 257 273.
19. Wee, J., Tan, E. H., Tai, B. C., Wong, H. B., Leong, S. S., Tan, T., Chua, E. T., Yang, E., Lee, K. M., Fong, K. W., Khoo, H. S., Tan, H. S. K., Lee, K. S., Loong, S., Sethi, V., Chua, E. J., and Machin, D. (2005). Randomized trial of radiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in patients with American Joint Committee on Cancer/International Union Against Cancer Stage III and IV nasopharyngeal cancer of the endemic variety. Journal of Clinical Oncology 23, 6730 6738.